Global Progesterone Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Natural Progesterone and Synthetic Progesterone.

By Mode of Delivery;

Injectable, Suspended Form, Oral and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn500599312 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Progesterone Market (USD Million), 2021 - 2031

In the year 2024, the Global Progesterone Market was valued at USD 4,870.35 million. The size of this market is expected to increase to USD 11,726.84 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 13.4%.

The global progesterone market encompasses pharmaceuticals, cosmetics, and dietary supplements, with progesterone being a crucial hormone in reproductive health and a range of medical conditions. In the pharmaceutical sector, progesterone is widely used in hormone replacement therapy (HRT) for menopausal women to alleviate symptoms like hot flashes and vaginal dryness. Additionally, it plays a vital role in fertility treatments, supporting embryo implantation and maintaining pregnancy. With the increasing prevalence of hormonal disorders and reproductive health issues, the demand for progesterone-based medications continues to rise, driving growth in the pharmaceutical segment of the market.

In the cosmetics industry, progesterone is utilized in skincare products for its purported anti-aging and moisturizing properties. Progesterone creams and serums are marketed as anti-wrinkle treatments and are believed to promote collagen production and improve skin elasticity. Furthermore, progesterone is incorporated into formulations targeting hormonal acne and other skin conditions associated with hormonal fluctuations. As consumers increasingly seek natural and bio-identical ingredients in their skincare products, the demand for progesterone-based cosmetics is expected to grow, bolstering the global progesterone market in the cosmetics segment.

Moreover, the dietary supplement market for progesterone is witnessing steady growth, driven by the rising awareness of hormonal balance and its impact on overall health and well-being. Progesterone supplements are marketed as a natural remedy for alleviating symptoms of premenstrual syndrome (PMS) and menopause, including mood swings, insomnia, and irregular menstrual cycles. Additionally, they are promoted for their potential benefits in supporting fertility and reproductive health. With consumers increasingly seeking alternative and complementary therapies to manage hormonal imbalances, the demand for progesterone supplements is expected to continue expanding, contributing to the growth of the global progesterone market in the dietary supplement segment.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Mode of Delivery
    3. Market Snapshot, By Region
  4. Global Progesterone Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Hormonal Disorders
        2. Demand for Hormone Replacement Therapy (HRT)
        3. Growing Awareness of Reproductive Health
      2. Restraints
        1. Regulatory Hurdles in Medications
        2. Safety Concerns and Side Effects
        3. Competition from Alternatives
      3. Opportunities
        1. Progesterone in Cosmetics
        2. Innovation in Formulations
        3. Rising Demand for Natural Hormone Products
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Progesterone Market, By Product Type, 2021 - 2031 (USD Million)
      1. Natural Progesterone
      2. Synthetic Progesterone
    2. Global Progesterone Market, By Mode of Delivery, 2021 - 2031 (USD Million)
      1. Injectable
      2. Suspended Form
      3. Oral
      4. Others
    3. Global Progesterone Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Merck KGaA
      2. Pfizer Inc.
      3. Bayer AG
      4. Abbott Laboratories
      5. Novartis AG
      6. Teva Pharmaceutical Industries Ltd.
      7. Mylan N.V.
      8. Besins Healthcare
      9. LGM Pharma
      10. Watson Pharmaceuticals (now part of Allergan)
  7. Analyst Views
  8. Future Outlook of the Market